APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anti-allergic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Anti-allergic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchOral Anti-allergic Drugs Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anti-allergic Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oral Anti-allergic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anti-allergic Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anti-allergic Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Oral Anti-allergic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Anti-allergic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Anti-allergic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anti-allergic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Anti-allergic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anti-allergic Drugs include Chongqing Huapont Pharmaceutical, Yangtze River Pharmaceutical Group, Teva, Sun Pharma, Sanofi, Johnson & Johnson, Hainan Poly Pharm, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Anti-allergic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Anti-allergic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Anti-allergic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Anti-allergic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Anti-allergic Drugs Segment by Company

Chongqing Huapont Pharmaceutical

Yangtze River Pharmaceutical Group

Teva

Sun Pharma

Sanofi

Johnson & Johnson

Hainan Poly Pharm

Novartis

Merck

Pfizer

GlaxoSmithKline

Dawnrays Pharma

Bayer

AstraZeneca

UCB Pharma

Boehringer Ingelheim

Almirall

Oral Anti-allergic Drugs Segment by Type

Immunosuppressant Drugs

Antihistamine Drugs

Allergic Mediator Release Agent

Oral Anti-allergic Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Oral Anti-allergic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anti-allergic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Anti-allergic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anti-allergic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Anti-allergic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Anti-allergic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Anti-allergic Drugs Industry Trends Table 2. Oral Anti-allergic Drugs Industry Drivers Table 3. Oral Anti-allergic Drugs Industry Opportunities and Challenges Table 4. Oral Anti-allergic Drugs Industry Restraints Table 5. Global Oral Anti-allergic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Anti-allergic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Anti-allergic Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oral Anti-allergic Drugs Sales Market Share by Manufacturers Table 9. Global Oral Anti-allergic Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oral Anti-allergic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Anti-allergic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Anti-allergic Drugs Manufacturers, Product Type & Application Table 13. Global Oral Anti-allergic Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Anti-allergic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immunosuppressant Drugs Table 17. Major Manufacturers of Antihistamine Drugs Table 18. Major Manufacturers of Allergic Mediator Release Agent Table 19. Global Oral Anti-allergic Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 21. Global Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 22. Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2026) Table 23. Global Oral Anti-allergic Drugs Sales Market Share by Type (2027-2032) Table 24. Global Oral Anti-allergic Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (k units) Table 26. Global Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (k units) Table 27. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Online Pharmacies Table 31. Major Manufacturers of Retail Pharmacies Table 32. Global Oral Anti-allergic Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 34. Global Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 35. Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2026) Table 36. Global Oral Anti-allergic Drugs Sales Market Share by Application (2027-2032) Table 37. Global Oral Anti-allergic Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (k units) Table 39. Global Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (k units) Table 40. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Oral Anti-allergic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Oral Anti-allergic Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Oral Anti-allergic Drugs Sales Market Share by Region (2021-2026) Table 45. Global Oral Anti-allergic Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Oral Anti-allergic Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 49. North America Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 50. Europe Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 52. Europe Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Oral Anti-allergic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Oral Anti-allergic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Oral Anti-allergic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2027-2032) Table 64. Chongqing Huapont Pharmaceutical Company Information Table 65. Chongqing Huapont Pharmaceutical Business Overview Table 66. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Portfolio Table 68. Chongqing Huapont Pharmaceutical Recent Development Table 69. Yangtze River Pharmaceutical Group Company Information Table 70. Yangtze River Pharmaceutical Group Business Overview Table 71. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Portfolio Table 73. Yangtze River Pharmaceutical Group Recent Development Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Teva Oral Anti-allergic Drugs Product Portfolio Table 78. Teva Recent Development Table 79. Sun Pharma Company Information Table 80. Sun Pharma Business Overview Table 81. Sun Pharma Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sun Pharma Oral Anti-allergic Drugs Product Portfolio Table 83. Sun Pharma Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Oral Anti-allergic Drugs Product Portfolio Table 88. Sanofi Recent Development Table 89. Johnson & Johnson Company Information Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Johnson & Johnson Oral Anti-allergic Drugs Product Portfolio Table 93. Johnson & Johnson Recent Development Table 94. Hainan Poly Pharm Company Information Table 95. Hainan Poly Pharm Business Overview Table 96. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hainan Poly Pharm Oral Anti-allergic Drugs Product Portfolio Table 98. Hainan Poly Pharm Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Novartis Oral Anti-allergic Drugs Product Portfolio Table 103. Novartis Recent Development Table 104. Merck Company Information Table 105. Merck Business Overview Table 106. Merck Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Merck Oral Anti-allergic Drugs Product Portfolio Table 108. Merck Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pfizer Oral Anti-allergic Drugs Product Portfolio Table 113. Pfizer Recent Development Table 114. GlaxoSmithKline Company Information Table 115. GlaxoSmithKline Business Overview Table 116. GlaxoSmithKline Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. GlaxoSmithKline Oral Anti-allergic Drugs Product Portfolio Table 118. GlaxoSmithKline Recent Development Table 119. Dawnrays Pharma Company Information Table 120. Dawnrays Pharma Business Overview Table 121. Dawnrays Pharma Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Dawnrays Pharma Oral Anti-allergic Drugs Product Portfolio Table 123. Dawnrays Pharma Recent Development Table 124. Bayer Company Information Table 125. Bayer Business Overview Table 126. Bayer Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bayer Oral Anti-allergic Drugs Product Portfolio Table 128. Bayer Recent Development Table 129. AstraZeneca Company Information Table 130. AstraZeneca Business Overview Table 131. AstraZeneca Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. AstraZeneca Oral Anti-allergic Drugs Product Portfolio Table 133. AstraZeneca Recent Development Table 134. UCB Pharma Company Information Table 135. UCB Pharma Business Overview Table 136. UCB Pharma Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. UCB Pharma Oral Anti-allergic Drugs Product Portfolio Table 138. UCB Pharma Recent Development Table 139. Boehringer Ingelheim Company Information Table 140. Boehringer Ingelheim Business Overview Table 141. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Boehringer Ingelheim Oral Anti-allergic Drugs Product Portfolio Table 143. Boehringer Ingelheim Recent Development Table 144. Almirall Company Information Table 145. Almirall Business Overview Table 146. Almirall Oral Anti-allergic Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Almirall Oral Anti-allergic Drugs Product Portfolio Table 148. Almirall Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Oral Anti-allergic Drugs Distributors List Table 152. Oral Anti-allergic Drugs Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Oral Anti-allergic Drugs Product Image Figure 2. Global Oral Anti-allergic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anti-allergic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anti-allergic Drugs Sales (2021-2032) & (k units) Figure 5. Global Oral Anti-allergic Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Anti-allergic Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immunosuppressant Drugs Image Figure 9. Antihistamine Drugs Image Figure 10. Allergic Mediator Release Agent Image Figure 11. Global Oral Anti-allergic Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Oral Anti-allergic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Oral Anti-allergic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Oral Anti-allergic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Oral Anti-allergic Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Oral Anti-allergic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Oral Anti-allergic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Oral Anti-allergic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Oral Anti-allergic Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Oral Anti-allergic Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Oral Anti-allergic Drugs Sales Market Share by Country (2021-2032) Figure 40. China Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Oral Anti-allergic Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Oral Anti-allergic Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Oral Anti-allergic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Oral Anti-allergic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Oral Anti-allergic Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral Anti-allergic Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immunosuppressant Drugs
  • Antihistamine Drugs
  • Allergic Mediator Release Agent
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Teva
  • Sun Pharma
  • Sanofi
  • Johnson & Johnson
  • Hainan Poly Pharm
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Dawnrays Pharma
  • Bayer
  • AstraZeneca
  • UCB Pharma
  • Boehringer Ingelheim
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Anti-allergic Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Anti-allergic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Anti-allergic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Anti-allergic Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Anti-allergic Drugs Market Dynamics
  1. 2.1 Oral Anti-allergic Drugs Industry Trends
  2. 2.2 Oral Anti-allergic Drugs Industry Drivers
  3. 2.3 Oral Anti-allergic Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Anti-allergic Drugs Industry Restraints
3 Oral Anti-allergic Drugs Market by Manufacturers
  1. 3.1 Global Oral Anti-allergic Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Anti-allergic Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Anti-allergic Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Anti-allergic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anti-allergic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Anti-allergic Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Oral Anti-allergic Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anti-allergic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anti-allergic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anti-allergic Drugs Tier 1, Tier 2, and Tier 3
4 Oral Anti-allergic Drugs Market by Type
  1. 4.1 Oral Anti-allergic Drugs Type Introduction
  2. 4.1.1 Immunosuppressant Drugs
  3. 4.1.2 Antihistamine Drugs
  4. 4.1.3 Allergic Mediator Release Agent
  5. 4.2 Global Oral Anti-allergic Drugs Sales by Type
  6. 4.2.1 Global Oral Anti-allergic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral Anti-allergic Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oral Anti-allergic Drugs Revenue by Type
  10. 4.3.1 Global Oral Anti-allergic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2032)
5 Oral Anti-allergic Drugs Market by Application
  1. 5.1 Oral Anti-allergic Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Oral Anti-allergic Drugs Sales by Application
  6. 5.2.1 Global Oral Anti-allergic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oral Anti-allergic Drugs Revenue by Application
  10. 5.3.1 Global Oral Anti-allergic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2032)
6 Global Oral Anti-allergic Drugs Sales by Region
  1. 6.1 Global Oral Anti-allergic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Anti-allergic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Anti-allergic Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Anti-allergic Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Anti-allergic Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Anti-allergic Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Anti-allergic Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Anti-allergic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Anti-allergic Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Anti-allergic Drugs Revenue by Region
  1. 7.1 Global Oral Anti-allergic Drugs Revenue by Region
  2. 7.1.1 Global Oral Anti-allergic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Anti-allergic Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Anti-allergic Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Anti-allergic Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Anti-allergic Drugs Revenue (2021-2032)
  8. 7.2.2 North America Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Anti-allergic Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Anti-allergic Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Anti-allergic Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Anti-allergic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Huapont Pharmaceutical
  2. 8.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 8.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Portfolio
  6. 8.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 8.2 Yangtze River Pharmaceutical Group
  8. 8.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 8.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Portfolio
  12. 8.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Oral Anti-allergic Drugs Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sun Pharma
  20. 8.4.1 Sun Pharma Company Information
  21. 8.4.2 Sun Pharma Business Overview
  22. 8.4.3 Sun Pharma Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharma Oral Anti-allergic Drugs Product Portfolio
  24. 8.4.5 Sun Pharma Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Oral Anti-allergic Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Oral Anti-allergic Drugs Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
  37. 8.7 Hainan Poly Pharm
  38. 8.7.1 Hainan Poly Pharm Company Information
  39. 8.7.2 Hainan Poly Pharm Business Overview
  40. 8.7.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hainan Poly Pharm Oral Anti-allergic Drugs Product Portfolio
  42. 8.7.5 Hainan Poly Pharm Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Oral Anti-allergic Drugs Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Oral Anti-allergic Drugs Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Oral Anti-allergic Drugs Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 GlaxoSmithKline
  62. 8.11.1 GlaxoSmithKline Company Information
  63. 8.11.2 GlaxoSmithKline Business Overview
  64. 8.11.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline Oral Anti-allergic Drugs Product Portfolio
  66. 8.11.5 GlaxoSmithKline Recent Developments
  67. 8.12 Dawnrays Pharma
  68. 8.12.1 Dawnrays Pharma Company Information
  69. 8.12.2 Dawnrays Pharma Business Overview
  70. 8.12.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dawnrays Pharma Oral Anti-allergic Drugs Product Portfolio
  72. 8.12.5 Dawnrays Pharma Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Oral Anti-allergic Drugs Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Oral Anti-allergic Drugs Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 UCB Pharma
  86. 8.15.1 UCB Pharma Company Information
  87. 8.15.2 UCB Pharma Business Overview
  88. 8.15.3 UCB Pharma Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 UCB Pharma Oral Anti-allergic Drugs Product Portfolio
  90. 8.15.5 UCB Pharma Recent Developments
  91. 8.16 Boehringer Ingelheim
  92. 8.16.1 Boehringer Ingelheim Company Information
  93. 8.16.2 Boehringer Ingelheim Business Overview
  94. 8.16.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Boehringer Ingelheim Oral Anti-allergic Drugs Product Portfolio
  96. 8.16.5 Boehringer Ingelheim Recent Developments
  97. 8.17 Almirall
  98. 8.17.1 Almirall Company Information
  99. 8.17.2 Almirall Business Overview
  100. 8.17.3 Almirall Oral Anti-allergic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Almirall Oral Anti-allergic Drugs Product Portfolio
  102. 8.17.5 Almirall Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Anti-allergic Drugs Value Chain Analysis
  2. 9.1.1 Oral Anti-allergic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Anti-allergic Drugs Production Mode & Process
  6. 9.2 Oral Anti-allergic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Anti-allergic Drugs Distributors
  9. 9.2.3 Oral Anti-allergic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst